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The Wnt-induced planar cell polarity (PCP) signaling pathway is essential for polarized cell migration and morphogen-
esis. Dishevelled (Dvl) and its binding protein Daam1 mediate RhoA activation in this pathway. WGEF, a member of the
Rho-guanine nucleotide exchange factor (Rho-GEF) family, was shown to play a role in Wnt-induced RhoA activation in
Xenopus embryos. However, it has remained unknown which member(s) of a Rho-GEF family are involved in Wnt/Dvl-
induced RhoA activation in mammalian cells. Here we identiﬁed p114-RhoGEF and Lfc (also called GEF-H1) as the
Rho-GEFs responsible for Wnt-3a–induced RhoA activation in N1E-115 mouse neuroblastoma cells. We screened for
Rho-GEF–silencing short-hairpin RNAs (shRNAs) that are capable of suppressing Dvl-induced neurite retraction in
N1E-115 cells and found that p114-RhoGEF and Lfc shRNAs, but not WGEF shRNA, suppressed Dvl- and Wnt-3a–induced
neurite retraction. p114-RhoGEF and Lfc shRNAs also inhibited Dvl- and Wnt-3a–induced RhoA activation, and p114-
RhoGEF and Lfc proteins were capable of binding to Dvl and Daam1. Additionally, the Dvl-binding domains of
p114-RhoGEF and Lfc inhibited Dvl-induced neurite retraction. Our results suggest that p114-RhoGEF and Lfc are
critically involved in Wnt-3a– and Dvl-induced RhoA activation and neurite retraction in N1E-115 cells.
INTRODUCTION
The Wnt family of secreted proteins play crucial roles in
numerous developmental and physiological processes by
regulating cell proliferation, migration, morphogenesis,
and polarity formation (Logan and Nusse, 2004). Wnt sig-
nals are transduced via at least three distinct pathways: a
canonical -catenin–dependent pathway and two nonca-
nonical -catenin–independent pathways, comprising a pla-
nar cell polarity (PCP) pathway and a Ca2 pathway (Vee-
man et al., 2003; Kikuchi et al., 2009). Dishevelled (Dvl) is a
key cytoplasmic component that is activated downstream of
the Wnt receptor Frizzled (Fz) to transduce both canonical
and noncanonical Wnt pathways (Wharton, 2003; Walling-
ford and Habas, 2005). In the canonical Wnt pathway, Dvl
mediates -catenin stabilization via suppression of GSK-3
activity, and the stabilized -catenin is translocated into the
nucleus where it stimulates the transcription of Wnt-respon-
sive genes (Logan and Nusse, 2004). In the noncanonical
Wnt-PCP pathway, Dvl mediates activation of Rho family
small GTPases, RhoA and Rac1, and their downstream ki-
nases, Rho-associated kinase (ROCK) and c-Jun N-terminal
kinase, respectively. This leads to actin cytoskeletal remod-
eling, which controls cell migration and PCP formation
(Veeman et al., 2003; Habas et al., 2003). The Wnt-PCP path-
way is required for the establishment of PCP of wing hairs,
bristles, and ommatidia in Drosophila (Shulman et al., 1998;
Adler, 2002). This pathway also functions in the processes of
polarized cell motility and morphogenesis in vertebrates,
including the convergent extension cell movements for an-
terior-posterior axis formation during Xenopus gastrulation
and the planar polarized orientation of stereocilia of sensory
hair cells in the mammalian inner ear (Jones and Chen, 2007;
Seifert and Mlodzik, 2007). The Dvl-mediated activation of
RhoA and ROCK is also involved in Wnt-3a–induced neu-
rite retraction in rat PC-12 pheochromocytoma and mouse
N1E-115 neuroblastoma cells (Kishida et al., 2004).
Rho family GTPases are inactive in the GDP-bound state
and active in the GTP-bound state, and in their active form
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3590these proteins can associate with downstream effector pro-
teins to induce a diverse cellular response (Etienne-Mannev-
ille and Hall, 2002). Guanine nucleotide exchange factors
(GEFs) stimulate the conversion of Rho GTPases from their
GDP-bound form to their active GTP-bound form (Schmidt
and Hall, 2002; Rossman et al., 2005). In the human genome,
there are at least 69 distinct members of the Dbl-related
Rho-GEF gene family, and these are thought to stimulate the
GDP–GTP exchange of Rho family GTPases (Rossman et al.,
2005). They possess a conserved Dbl homology (DH) do-
main responsible for Rho-GEF activity, and the DH domain
is usually followed by a pleckstrin homology (PH) domain
that mediates membrane association. In addition to the DH
and PH domains, the Dbl-family Rho-GEFs contain a variety
of protein-binding domains that are thought to be involved
in the distinct regulation of GEF activity or the localization
of individual Rho-GEFs (Rossman et al., 2005). Because of the
large number of Rho-GEF genes in mammalian genomes,
the functional roles of each of the individual Rho-GEFs in
various cellular events have not been elucidated.
In the Wnt/PCP pathway, Wnt/Fz/Dvl-induced RhoA
activation requires a formin-related protein, termed the Dvl-
associated activator of morphogenesis 1 (Daam1) (Habas et
al., 2001). When Fz is activated by the Wnt signal, it induces
the translocation of Dvl to the plasma membrane and the
formation of the Dvl-Daam1 complex. Because Daam1 does
not have the ability to activate RhoA directly, it is predicted
to function as a scaffold protein that recruits Rho-GEF for
RhoA activation (Habas et al., 2001). A recent study showed
that WGEF (named in this manner because of its weak
similarity to GEF), a member of the Dbl-related Rho-GEFs,
connects Dvl to Rho activation in the Wnt/PCP pathway
and controls the convergent extension process in Xenopus
gastrulation (Tanegashima et al., 2008). Xenopus WGEF can
bind to Dvl and Daam1, and depletion of WGEF caused axis
elongation defects and inhibition of convergent extension in
Xenopus embryos (Tanegashima et al., 2008). However, it is
unknown whether WGEF, or other Rho-GEFs, are involved
in Dvl-induced RhoA activation in other cells, tissues, and
species.
In this study, we aimed to identify Rho-GEFs that are
involved in the Wnt-PCP pathway in mammalian cells. Pre-
vious studies have shown that Dvl activates RhoA and
ROCK, thereby inhibiting serum starvation-induced neurite
outgrowth in N1E-115 mouse neuroblastoma cells (Kishida
et al., 2004). To identify Rho-GEFs that are responsible for
Dvl-induced RhoA activation, we constructed effective
short-hairpin RNAs (shRNAs) targeting 14 Rho-GEFs (in-
cluding WGEF) that are expressed in N1E-115 cells and
analyzed the effects of these shRNAs on Dvl-induced neurite
retraction in N1E-115 cells. We provide evidence that p114-
RhoGEF and Lfc (also called GEF-H1) are involved in Wnt-




Recombinant mouse Wnt-3a was purchased from R&D Systems (Minneapolis,
MN). Rabbit polyclonal antibodies against LARG (sc-25638; Santa Cruz Bio-
technology, Santa Cruz, CA), p115-RhoGEF (H-165; Santa Cruz), and green
ﬂuorescent protein (GFP) (A6455; Molecular Probes, Eugene, OR), goat poly-
clonal antibodies against p114-RhoGEF (ab10152; Abcam, Cambridge, MA)
and Lfc (sc-9334; Santa Cruz), mouse monoclonal antibodies against RhoA
(sc-418; Santa Cruz), -actin (AC-15; Sigma-Aldrich, St. Louis, MO), Myc
(9E10; Roche, Welwyn Garden City, UK), and Flag (F3165; Sigma-Aldrich),
and a rat mAb against hemagglutinin (HA) epitope (3F10; Roche) were
purchased commercially.
Cell Culture and Transfection
N1E-115 (provided by Dr. S. Narumiya, Kyoto University), GP2–293 (Clon-
tech, Cambridge, UK), and HEK293T cells (American Type Culture Collec-
tion, Manassas, VA) were maintained in Dulbecco’s Modiﬁed Eagle’s Me-
dium (DMEM) supplemented with 15%, 10%, and 10% fetal calf serum,
respectively. Jurkat T-cells (Cell Resource Center, Tohoku University) were
maintained in RPMI 1640 medium supplemented with 10% fetal calf serum.
Wnt-3a–producing L cells were provided by Dr. S. Takada (National Institute
for Natural Sciences, Okazaki, Japan) and maintained in DMEM supple-
mented with 5% fetal calf serum and 1.5 mg/ml sodium bicarbonate (Shi-
bamoto et al., 1998). Cells were transfected with plasmids using FuGENE6
(Roche) or Lipofectamine 2000 (Invitrogen, San Diego, CA).
Reverse Transcription (RT)-PCR
To examine the expression proﬁle of Rho-GEF mRNAs, total RNA isolated
from N1E-115 cells using an RNeasy Mini Kit (Qiagen, Hilden, Germany) was
reverse-transcribed to yield single-stranded cDNA using the SuperScript
Choice System (Invitrogen). cDNA was subjected to PCR ampliﬁcation for
30 cycles with each cycle consisting of denaturation at 94°C for 30 s, primer
annealing at 55°C for 30 s, and extension at 72°C for 30 s. The speciﬁc
primers used for amplifying the 16 Rho-GEF cDNAs are listed in Supple-
mental Table S1.
Plasmid Construction
The cDNAs for human LARG (KIAA0382), p114-RhoGEF (KIAA0521), and
Lfc (KIAA0651) were provided by Dr. T. Nagase (Kazusa DNA Research
Institute, Kisarazu, Japan). The 5 partial sequence of LARG cDNA was
ampliﬁed by RT-PCR from human brain total RNA. The cDNA for mouse
WGEF was purchased from Open Biosystems (Huntsville, AL). Plasmids
coding for Flag-Dvl-1 and Myc-Daam1 were provided by Dr. H. Shibuya
(Tokyo Medical and Dental University) and Drs. Y. Kida and T. Ogura
(Tohoku University), respectively. Expression plasmids coding for cyan ﬂu-
orescent protein (CFP)-tagged LARG, p114-RhoGEF, Lfc (amino acids 20-985),
WGEF, and Dvl-1 were constructed by inserting the PCR-ampliﬁed cDNAs
into the pECFP-C1 vector (Clontech). A plasmid encoding HA-WGEF was
constructed by subcloning WGEF cDNA into the pUCD2–3HA vector. Ex-
pression plasmids for truncated mutants of CFP-p114-RhoGEF, CFP-Lfc, Flag-
Dvl-1, and Myc- or HA-Daam1 were constructed by inserting PCR-ampliﬁed
fragments into pECFP-C1, FPC-Myc, and pUCD2–3HA expression vectors.
For monitoring the silencing efﬁciency of Rho-GEF shRNAs, pNUL-Rho-GEF
plasmids were constructed by inserting the Photinus pyralis luciferase cDNA
from pGL4.10 (Promega, Madison, WI) and the partial (400 base pairs)
cDNA of each Rho-GEF, prepared by RT-PCR from total RNA of N1E-115
cells, into the NcoI-NotI site of the pNAMA-U6 retrovirus vector (Shirane et al.,
2004).
Construction of an shRNA Library and Screening for
Effective shRNA Constructs
To construct an shRNA library targeting each Rho-GEF, the partial cDNA
(400 base pairs) of Rho-GEF was obtained by PCR ampliﬁcation from the
pNUL-Rho-GEF plasmid. An shRNA library was then produced from this
cDNA fragment, according to the enzymatic production of RNAi library
(EPRIL) method, as described previously (Shirane et al., 2004). All shRNA
constructs were inserted into the pNAMA-U6 retrovirus vector (Shirane et al.,
2004). For screening of effective shRNAs, an shRNA-carrying retrovirus was
produced in 96-well plates. Plasmids were prepared using a Perfectprep
Plasmid 96 Vac (Eppendorf, Hamburg, Germany), according to the manufac-
turer’s protocol. GP2–293 packaging cell lines were transfected with 200 ng
of the shRNA-carrying pNAMA-U6 plasmid or pNUL-RhoGEF, and 17 ng of
the VSV-G-encoding plasmid using FuGENE6. Two days after transfection,
the retrovirus-containing culture medium was collected. Jurkat cells (1.0 
105 cells per ml) suspended in 50 l medium were coinfected with 50 lo ft h e
medium containing retrovirus particles (25 l each of medium containing
retrovirus carrying the shRNA constructs and pNUL-RhoGEF) in 96-well
white polystyrene plates (Corning, Corning, NJ). Two days later, the cells
were lysed with 90 l of Bright-Glo Assay System reagents (Promega), and
the relative levels of luciferase expression were estimated by measuring
luminescent intensity using an LMax II luminometer (Molecular Devices,
Sunnyvale, CA). The relative reduction of luciferase activity was used as a
measure of silencing efﬁciency. The authenticity of all effective shRNA con-
structs was conﬁrmed by nucleotide sequence analysis (target sequences are
listed in Supplemental Table S2). For each target gene, 30–96 independent
shRNA constructs were screened. Each screening was repeated three times,
and clones with a high efﬁcacy of gene silencing were selected.
Neurite-bearing Cell Scoring Assay
N1E-115 cells were plated on glass coverslips pretreated with 1 g/ml poly-
L-lysine, cultured for 24 h, and transfected with CFP expression plasmids
and/or shRNA plasmids using Lipofectamine 2000. After incubation for
24 h, cells were serum-starved for 24 h and then ﬁxed with 4% formalde-
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longer than one cell body length were scored as neurite-bearing cells. More
than 50 cells were evaluated for each experiment. All data are indicated as
means  SD. To examine the effects of Wnt-3a–induced neurite retraction,
Wnt-3a conditioned medium (CM) was prepared as described previously
(Shibamoto et al., 1998).
Immunoprecipitation and Immunoblot Analysis
Cells were lysed with ice-cold lysis buffer (50 mM HEPES, pH 7.4, 150 mM
NaCl, 0.5% Nonidet P-40, 5% glycerol, 1 mM MgCl2, 1 mM MnCl2,1m M
Na3VO4, 10 mM NaF, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
ﬂuoride, and 10 g/ml leupeptin). Cell lysates were subjected to immuno-
precipitation and immunoblot analysis, as described previously (Ohashi et al.,
2000).
Pull-Down Assay of RhoA Activity
An active GTP-bound form of RhoA was analyzed via pull-down assays
using glutathione-S-transferase (GST) fusion proteins of the Rho-binding
domain (RBD) of rhotekin, as described previously (Ren et al., 1999; Nishita et
al., 2002). N1E-115 cells were cotransfected with CFP-Dvl-1 and shRNAs
targeting LARG, p114-RhoGEF, or Lfc and cultured for 48 h. Cell lysates were
then incubated with GST-RBD bound to glutathione-Sepharose. The bead
pellets were washed and analyzed by immunoblotting using an anti-RhoA
antibody.
Statistical Analysis
Statistical data are expressed as means  SD of three independent experi-
ments. When appropriate, one-tailed Student’s t test was applied. In all cases,
p  0.05 was considered statistically signiﬁcant.
RESULTS
Expression Proﬁle of Rho-GEFs in N1E-115 Cells
The human genome encodes at least 69 Dbl-like Rho family
GEFs, of which 16 members were reported to exhibit GEF
activity preferentially activating RhoA (Rossman et al., 2005).
As the ﬁrst step to identify Rho-GEFs that are involved in
Dvl-induced RhoA activation in N1E-115 cells, we analyzed
the expression proﬁle of these 16 Rho-GEF transcripts in
N1E-115 cells by RT-PCR analysis, using primers listed in
Supplemental Table S1. RT-PCR analyses revealed that 13
Rho-GEFs (p115-RhoGEF, PDZ-RhoGEF, LARG, p114-
RhoGEF, Lbc/AKAP, Lfc/GEF-H1, Net1, ECT2, Scambio,
p164-RhoGEF, Vsm-RhoGEF, CDEP/Farp1, and TrioC)
were expressed in N1E-115 cells, but the expression of the
other three Rho-GEFs (XPLN, Tim1, and NGEF/Ephexin)
was not detected (Figure 1A). Because WGEF was recently
reported to be involved in RhoA activation in the Wnt-
PCP pathway in Xenopus embryos (Tanegashima et al.,
2008), we also examined the expression of the mouse
ortholog of WGEF in N1E-115 cells by RT-PCR analysis
and detected the expression of WGEF in N1E-115 cells
(Figure 1A).
Selection of Effective shRNA Constructs Targeting
Rho-GEFs
To identify which members of the Rho-GEF family are in-
volved in Dvl-induced RhoA activation, we planned to
search for the Rho-GEF shRNAs that suppress Dvl-induced
neurite retraction in N1E-115 cells. To obtain effective
shRNA constructs against each of the Rho-GEFs expressed
in N1E-115 cells, we developed a screening method sche-
matically shown in Figure 1B. Using an EPRIL method
(Shirane et al., 2004), we produced an shRNA library con-
sisting of an array of different shRNA constructs from the
PCR-ampliﬁed cDNA fragment (400 base pairs) of each
Rho-GEF. Each shRNA construct from the EPRIL library
was introduced into Jurkat cells together with the reporter
gene construct, encoding a chimeric cDNA composed of
luciferase and the cDNA fragment of the target gene
(Zhao et al., 2005). If any shRNA construct effectively
suppresses expression of its target gene, luciferase expres-
sion will be simultaneously reduced. Thus, the silencing
effect of each shRNA on target gene expression can be
easily monitored by measuring luciferase activity. Using
this reporter assay, two effective shRNA constructs tar-
geting each of the 13 mouse Rho-GEFs were selected
(Figure 1C), and the target sequences are listed in Sup-
plemental Table S2. The target speciﬁcity of the selected
shRNA constructs was assessed by luciferase reporter
assays. The shRNA constructs for LARG, p114-RhoGEF,
and Lfc suppressed the expression of the corresponding
RhoGEF-luciferase chimeric proteins but not the expres-
sion of the irrelevant RhoGEF-luciferase chimeric proteins
(Supplemental Figure S1), indicating that each of the se-
lected shRNAs has the target speciﬁcity. Immunoblot
analyses of endogenous LARG, p114-RhoGEF, Lfc, and
p115-RhoGEF proteins revealed that the shRNA con-
structs selected by our method effectively suppressed ex-
pression of their target protein in N1E-115 cells (Figure 1D
and Supplemental Figure S2). We also constructed an
shRNA plasmid targeting mouse WGEF. When coex-
pressed with HA-tagged WGEF in N1E-115 cells, the
shRNA targeting WGEF effectively suppressed the ex-
pression of HA-WGEF (Figure 1D).
Knockdown of LARG, p114-RhoGEF, or Lfc Suppresses
Dvl-Induced Neurite Retraction
N1E-115 cells extend neurites under serum-starved condi-
tions (Jalink et al., 1994; Kozma et al., 1997), but treatment of
the cells with Wnt-3a or overexpression of Dvl suppresses
serum starvation-induced neurite outgrowth through the
activation of the RhoA-ROCK pathway (Kishida et al., 2004).
To identify Rho-GEFs that are involved in the Wnt/PCP
pathway, we examined the effect of each Rho-GEF shRNA
on Dvl-induced neurite retraction in N1E-115 cells. The cells
were cotransfected with the shRNA construct targeting each
of the Rho-GEFs and the plasmid encoding CFP or CFP-
tagged Dvl-1. The transfected cells were cultured for 24 h,
serum-starved for 24 h, and then ﬁxed (Figure 2A). To
quantitate the effects of shRNAs on neurite outgrowth, we
scored the percentage of neurite-bearing cells with neurite(s)
longer than one cell body length in CFP-positive cells (Fig-
ure 2B). Under the serum-starved conditions, more than
60% of cells transfected with control CFP extended neu-
rites, but expression of CFP-Dvl-1 signiﬁcantly reduced
the percentage of neurite-bearing cells to 30% (Figure
2B). Similar to the results in a previous report (Kishida et
al., 2004), Dvl-1 fragments (1-367) and (165-670), but not
(1-167), suppressed serum starvation-induced neurite out-
growth (Supplemental Figure S3), indicating the impor-
tance of the central region of Dvl-1 for its neurite retrac-
tion activity.
Interestingly, cotransfection of the shRNAs targeting
LARG, p114-RhoGEF, or Lfc with CFP-Dvl-1 signiﬁcantly
increased the percentage of neurite-bearing cells, compared
with the cells cotransfected with control shRNA (Figure 2, A
and B). In contrast, no signiﬁcant change in Dvl-induced
neurite retraction was observed by cotransfection of the
other Rho-GEF shRNAs (Figure 2B). WGEF shRNA had no
apparent effect on Dvl-induced neurite retraction in N1E-
115 cells (Figure 2, A and C). Cotransfection of shRNA-
resistant LARG, p114-RhoGEF, or Lfc cDNA with the
corresponding Rho-GEF shRNA reversed the inhibitory
effects of Rho-GEF shRNAs on Dvl-induced neurite re-
traction (Supplemental Figure S4). In addition, knock-
down of LARG, p114-PhoGEF, Lfc, or WGEF had no
signiﬁcant effect on the percentage of neurite-bearing cells
T. Tsuji et al.
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plemental Figure S5). These results suggest that LARG,
p114-RhoGEF, and Lfc are the Rho-GEFs involved in Dvl-
induced neurite retraction, and other Rho-GEFs, including
WGEF, are not related to this process in N1E-115 cells. As
previously reported (Kishida et al., 2004), Y-27632, an inhib-
itor of ROCK, blocked Dvl-induced neurite retraction (data
not shown), indicating that Dvl-1–induced neurite retraction
involves ROCK activation.
Effects of the Knockdown of RhoGEFs on Wnt-3a– or
Lysophosphatidic Acid–Induced Neurite Retraction
Previous studies showed that both Wnt-3a and lysophos-
phatidic acid (LPA) induce neurite retraction in N1E-115
cells (Jalink et al., 1994; Kozma et al., 1997; Kishida et al.,
2004). To determine the functional speciﬁcity of Rho-GEFs,
we examined whether the knockdown of LARG, p114-Rho-
GEF, or Lfc affects Wnt-3a– or LPA-induced neurite retrac-
tion in N1E-115 cells. Treatment of the cells with CM of
Wnt-3a–producing L cells signiﬁcantly decreased the num-
ber of neurite-bearing cells, but CM of control L cells had no
effect (Figure 3). Knockdown of LARG, p114-RhoGEF, or Lfc
by shRNA transfection markedly inhibited Wnt-3a CM-in-
duced neurite retraction (Figure 3). Similar results were
obtained when we used puriﬁed recombinant Wnt-3a in
place of Wnt-3a CM (Supplemental Fig. S6). These results
indicate that these three Rho-GEFs are involved in Wnt-
3a–induced neurite retraction. In contrast, when we ana-
lyzed the effects of Rho-GEF knockdown on LPA-induced
neurite retraction in N1E-115 cells, LARG shRNA signif-
icantly blocked LPA-induced neurite retraction but p114-
RhoGEF and Lfc shRNAs had only partial or no effects
(Figure 3). In addition, WGEF shRNA had no apparent
effect on Wnt-3a– or LPA-induced neurite retraction (Sup-
plemental Figure S7). These results suggest that p114-
RhoGEF and Lfc preferentially function in Wnt-3a–in-
Figure 1. Screening of effective shRNA constructs targeting Rho-GEFs expressed in N1E-115 cells. (A) Expression of Rho-GEF mRNAs in
N1E-115 cells. Total RNAs from N1E-115 cells were subjected to RT-PCR analysis using primers designed to amplify PCR products of 400
base pairs in length. Experiments were repeated twice, and similar results were obtained. (B) Schematic of the protocol for selecting effective
shRNA constructs. The cDNA fragment (400 base pairs) of a target gene is fused to the 3 terminus of luciferase cDNA and infected into
Jurkat cells together with each individual shRNA construct from an RNAi library constructed by an EPRIL method. Effective shRNA
constructs target the cognate sequences of the target gene on the luciferase-target chimeric mRNA, thus preventing luciferase expression. (C)
Luciferase reporter analysis to select shRNA constructs targeting each of 13 Rho-GEFs. Jurkat cells were coinfected with retroviruses carrying
a luciferase-target chimeric gene together with retroviruses carrying shRNA constructs targeting each Rho-GEF. The relative luminescent
intensity for each type of shRNA-infected cells was compared with that for shRNA noninfected control cells. Data represent means  SD of
triplicate experiments. The target sequences for Rho-GEFs are listed in Supplemental Table S2. (D) Immunoblot analysis of Rho-GEF
expression. N1E-115 cells were transfected with the indicated shRNA (#1) and cultured for 48 h. Expression of endogenous Rho-GEF proteins
or cotransfected HA-WGEF was analyzed by immunoprecipitation (IP) followed by immunoblotting (IB) with the indicated antibodies. Actin
in cell lysates was analyzed as a loading control.
Rho-GEFs for Dvl-Induced RhoA Activation
Vol. 21, October 15, 2010 3593duced neurite retraction, but LARG plays a more general
role in neurite retraction, being responsive to two distinct
types of extracellular cues.
Knockdown of p114-RhoGEF or Lfc Suppresses Dvl- or
Wnt3a-Induced RhoA Activation
We next examined the effects of knockdown of LARG, p114-
RhoGEF, or Lfc on Dvl- or Wnt-3a–induced RhoA activation
in N1E-115 cells. RhoA activity was assessed by GST pull-
down assays using the GST-tagged Rho-binding domain
(RBD) of rhotekin, to which only the active GTP-bound form
of RhoA binds (Ren et al., 1999; Nishita et al., 2002). The level
of active RhoA increased about threefold in cells transfected
with Dvl-1, compared with nontransfected cells. When N1E-
115 cells were cotransfected with Dvl-1 and each of the
Rho-GEF shRNAs, Dvl-induced RhoA activation was signif-
icantly suppressed by p114-RhoGEF or Lfc shRNA but not
by LARG shRNA (Figure 4A). Similarly, Wnt-3a–induced
RhoA activation was suppressed by p114-RhoGEF or Lfc
shRNA, but not signiﬁcantly by LARG shRNA (Figure 4B).
These results suggest that p114-RhoGEF and Lfc, but not
LARG, play major roles in Dvl- and Wnt-3a–induced RhoA
activation in N1E-115 cells.
Effects of Double Knockdown of p114-RhoGEF and Lfc on
Dvl- or Wnt-3a–Induced RhoA Activation and Neurite
Retraction
To examine the relationships between the roles of p114-
RhoGEF and Lfc in Wnt-3a and Dvl signaling, we analyzed
the effects of double knockdown of p114-RhoGEF and Lfc on
Dvl- or Wnt-3a–induced RhoA activation and compared them
with the effects of p114-RhoGEF or Lfc single knockdown. As
shown in Figure 4, p114-RhoGEF/Lfc double knockdown sup-
pressed Dvl-1- or Wnt-3a–induced RhoA activation to the ex-
tent similar to those by p114-RhoGEF or Lfc single knockdown.
Furthermore, p114-RhoGEF/Lfc double knockdown sup-
pressed Dvl-1–induced neurite retraction to the extent similar
to those by p114 or Lfc single knockdown (Supplemental
Figure S8). These results suggest that p114-RhoGEF and Lfc
function in a similar pathway and that these Rho-GEF ac-
tivities may depend on each other.
p114-RhoGEF and Lfc, but Not LARG, Bind to Dvl and
Daam1
We next examined whether p114-RhoGEF, Lfc, and LARG
would physically interact with Dvl. When Flag-tagged Dvl-1
Figure 2. Knockdown of LARG, p114-Rho-
GEF, or Lfc, but not WGEF, suppresses Dvl-
induced neurite retraction. (A) Effects of Rho-
GEF knockdown on Dvl-induced neurite
retraction. N1E-115 cells were cotransfected
with CFP-Dvl-1 (or control CFP) and the indi-
cated shRNA plasmids at the ratio of 1:2, cul-
tured for 24 h, serum-starved for 24 h, and then
ﬁxed. Merged images of phase-contrast and
CFP ﬂuorescence are shown. Scale bar, 50 m.
(B) Quantitative analysis of the percentage of
neurite-bearing cells. Cells with neurites ex-
ceeding one cell body length were scored and
expressed as a percentage of the total number
of CFP-positive cells. Data represent means 
SD of three independent experiments (at least
50 cells in each experiment). *p  0.01. (C)
Effects of WGEF shRNA and the indicated
shRNA (#1) on Dvl-induced neurite retraction.
Quantitative analysis of the percentage of neu-
rite-bearing cells was performed as in (B).
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LARG in HEK293T cells and immunoprecipitated with an
anti-Flag antibody, p114-RhoGEF and Lfc, but not LARG,
were coprecipitated with Flag-Dvl-1 (Figure 5A). We also
analyzed the interactions between Daam1 and each of the
Rho-GEFs. When Myc-tagged Daam1 was coexpressed with
each of the CFP-tagged Rho-GEFs in HEK293T cells and
immunoprecipitated with an anti-Myc antibody, p114-Rho-
GEF and Lfc, but not LARG, were coprecipitated with Myc-
Daam1 (Figure 5B). Precipitation of CFP-p114-RhoGEF and
CFP-Lfc was not detected when we used the irrelevant
antibodies for coimmunoprecipitation analyses (Supplemen-
tal Figure S9). We also analyzed the binding of WGEF to
Dvl-1 and Daam1. CFP-WGEF was coprecipitated with Flag-
Dvl-1 and Myc-Daam1 (Figure 5, A and B), as previously
reported (Tanegashima et al., 2008). Additionally, Myc-
Daam1 was coprecipitated with Flag-Dv1–1 (Figure 5C), as
previously reported (Habas et al., 2001). We next examined
the binding of endogenous Dvl-1 to endogenous p114-Rho-
GEF or Lfc in N1E-115 cells. When N1E-115 cells were
treated with Wnt-3a CM or left untreated and cell lysates
were immunoprecipitated with an anti-p114-Rho-GEF or an
anti-Lfc antibody, Dvl-1 was coprecipitated with each of
these Rho-GEFs and the interactions between Dvl-1 and
these Rho-GEFs increased after treatment with Wnt-3a CM
(Figure 5D). These results suggest that p114-RhoGEF and
Lfc are involved in Wnt-3a– and Dvl-1–mediated RhoA ac-
tivation by associating with Dvl-1 and Daam1. In contrast,
LARG did not bind to Dvl-1 or Daam1, and knockdown of
LARG had no signiﬁcant effect on Wnt-3a– or Dvl-1–in-
duced RhoA activation, thus indicating that LARG is not
directly involved in Wnt-3a– or Dvl-1–induced RhoA acti-
vation.
Mapping of the Binding Regions of Dvl, Daam1,
p114-RhoGEF, and Lfc
Dvl proteins have three conserved domains, termed DIX,
PDZ, and DEP (Lee et al., 1999). To determine which region
of Dvl is involved in binding to p114-RhoGEF and Lfc,
deletion mutants of Flag-Dvl-1 were coexpressed with CFP-
p114-RhoGEF or CFP-Lfc, and their binding ability was
analyzed by coimmunoprecipitation using an anti-Flag an-
tibody. As shown in Figure 6A, both CFP-p114-RhoGEF and
CFP-Lfc coprecipitated with Dvl-1-(amino acids 165-367),
but not with Dvl-1-(1-167) or Dvl-1-(326-670), indicating
that Dvl-1 binds to p114-RhoGEF and Lfc through the
central PDZ-containing region (165-367). We also ana-
lyzed the binding of each Rho-GEF to the N- and C-
terminal fragments of Daam1 [N-Daam1 (amino acids
1-235) and C-Daam1 (490-1078)] (Figure 6B). p114-Rho-
GEF and Lfc coprecipitated with Myc-tagged full-length
Daam1 and HA-tagged N-Daam1 but not Myc-tagged
C-Daam1, indicating that Daam1 binds to these Rho-GEFs
through its N-terminal region.
To map the regions of p114-RhoGEF and Lfc required
for binding to Dvl and Daam1, we constructed deletion
mutants of CFP-p114-RhoGEF and CFP-Lfc and analyzed
their binding abilities to Flag-Dvl-1-(165-367) or HA-N-
Daam1 by coimmunoprecipitation assays. As shown in
Figure 3. Effects of knockdown of LARG, p114-RhoGEF, or Lfc on
neurite retraction induced by Wnt-3a CM or LPA. N1E-115 cells
were cotransfected with CFP and LARG, p114-RhoGEF, or Lfc
shRNA at the ratio of 1:5 and serum-starved for 24 h. Cells were
treated for 10 min with control (L cell) CM, Wnt-3a–producing L cell
CM, or LPA. The percentages of neurite-bearing cells in CFP-posi-
tive cells were counted. Data represent means  SD of three inde-
pendent experiments (at least 50 cells in each experiment). *p  0.01.
Figure 4. Effects of single knockdown of
LARG, p114-RhoGEF, or Lfc, or double knock-
down of p114-RhoGEF and Lfc, on RhoA acti-
vation induced by Dvl-1 (A) or Wnt-3a (B). In
A, N1E-115 cells were cotransfected with CFP
or CFP-Dvl-1 and shRNA constructs, cultured
for 24 h, and serum-starved for 24 h. In B,
N1E-115 cells transfected with shRNAs were
cultured for 24 h, serum-starved for 24 h, and
treated with control or Wnt-3a CM for 10 min.
The level of active RhoA was analyzed by a
GST-RBD pull-down assay. Relative activity of
RhoA was normalized by the immunoblot in-
tensity of RhoA in the total cell lysates. Data
represent means  SD of three independent
experiments, with the level in control cells
taken as 1.0. *p  0.01.
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(1-572), coprecipitated with Flag-Dvl-1-(165-367). Con-
versely, p114-RhoGEF-(1-572), but not p114-RhoGEF-
(568-1016), coprecipitated with HA-N-Daam1. Thus,
p114-RhoGEF binds to Dvl-1-(165-367) through its C-ter-
minal region and to N-Daam1 through its N-terminal
DH-PH–containing region. Figure 7B shows the results of
coprecipitation assays between Lfc fragments and Flag-
Dvl-1-(165-367) or HA-N-Daam1. Flag-Dvl-1-(165-367) co-
precipitated with Lfc-(1-155) but not Lfc-(151-655) or Lfc-
(650-970). In contrast, HA-N-Daam1 coprecipitated with
Lfc-(151-655) but not Lfc-(1-155) or Lfc-(650-970). These re-
sults suggest that Lfc binds to Dvl-1-(165-367) through its
N-terminal region and to N-Daam1 through its central DH-
PH–containing region.
Because we observed the binding of Daam1 to the
DH/PH domain of p114-RhoGEF and Lfc, we next asked
whether the DH/PH domain of Rho-GEFs would commonly
have a potential to bind to Daam1. When Myc-Daam1 was
coexpressed with CFP-tagged DH/PH domain of LARG,
p114-Rho-GEF, Lfc, or WGEF and immunoprecipitated with
an anti-Myc antibody, the DH/PH domain of each Rho-
GEFs was coprecipitated with Myc-Daam1, although the
binding of the DH/PH domain of LARG was weaker than
those of p114-RhoGEF and Lfc (Supplemental Figure S10).
These results suggest that the DH/PH domains of these four
Rho-GEFs commonly have the capacity to bind to Daam1
and that the Daam1-binding ability of the DH/PH domain
of LARG may be masked in a full-length form by the in-
tramolecular interaction.
Figure 5. Binding of p114-RhoGEF, Lfc, and WGEF, but not
LARG, to Dvl and Daam1. (A) Binding to Dvl. Flag-tagged Dvl-1
was coexpressed with CFP-tagged Rho-GEFs in HEK293 cells.
Cell lysates were immunoprecipitated with an anti-Flag antibody
and immunoblotted with anti-GFP and anti-Flag antibodies. (B)
Binding to Daam1. Myc-tagged Daam1 was coexpressed with
CFP-tagged Rho-GEFs in HEK293 cells. Cell lysates were immu-
noprecipitated with an anti-Myc antibody and immunoblotted
with anti-GFP and anti-Myc antibodies. (C) Binding of Daam1 to
Dvl. Myc-Daam1 and Flag-Dvl-1 were coexpressed in HEK293
cells. Cell lysates were immunoprecipitated with an anti-Flag
antibody and analyzed by immunoblotting with anti-Myc and
anti-Flag antibodies. (D) Binding of endogenous proteins. N1E-
115 cells were serum-starved for 24 h and treated with Wnt-3a
CM for 10 min or left untreated. Cell lysates were immunopre-
cipitated with an anti–p114-RhoGEF or an anti-Lfc antibody and
immunoblotted with anti–Dvl-1, anti–p114-RhoGEF, and anti-Lfc
antibodies. All experiments were repeated twice, and similar
results were obtained.
Figure 6. Mapping of the binding regions of Dvl and Daam1. (A)
Binding of p114-RhoGEF and Lfc to the middle region of Dvl.
Flag-tagged Dvl-1 fragments and CFP-tagged p114-RhoGEF or
Lfc were coexpressed in HEK293 cells. Cell lysates were immu-
noprecipitated with an anti-Flag antibody and analyzed by im-
munoblotting with anti-GFP and anti-Flag antibodies. (B) Bind-
ing of p114-RhoGEF and Lfc to the N-terminal region of Daam1.
Myc- or HA-tagged Daam1 fragments and CFP-tagged Rho-GEFs
were coexpressed in HEK293 cells and analyzed as in A. In A and
B, schematic structures of Dvl-1, Daam1 and their fragments are
shown.
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or Lfc Suppresses Dvl-Induced Neurite Retraction
We analyzed the effects of overexpression of the Dvl-binding
fragment of p114-RhoGEF or Lfc on Dvl-induced neurite
retraction. N1E-115 cells were cotransfected with Flag-Dvl-1
and CFP-tagged p114-RhoGEF or Lfc fragments and the
percentages of neurite-bearing cells were analyzed. Coex-
pression of Dvl-binding fragments [p114-RhoGEF-(568-
1016) or Lfc-(1-155)] signiﬁcantly suppressed Dvl-induced
neurite retraction, while coexpression of Dvl-nonbinding
fragments [Lfc-(650-970)] did not affect on it (Figure 8, A and
B). In addition, coexpression of p114-RhoGEF-(1-572) had no
apparent effect on Dvl-induced neurite retraction, probably
because this fragment contains the DH/PH domain and
functions as an active form of p114-RhoGEF by truncation of
the C-terminal extracatalytic region. These observations sug-
gest that the Dvl-binding fragments of p114-RhoGEF and
Lfc suppress Dvl-induced neurite retraction and function as
the dominant-negative forms of Rho-GEFs.
Because previous studies showed that N-Daam1 sup-
pressed Dvl-induced RhoA activation (Habas et al., 2001; Liu
et al., 2008), we analyzed the effects of expression of N-
Daam1 on Dvl-induced RhoA activation in N1E-115 cells.
Coexpression of N-Daam1 with Dvl-1 signiﬁcantly sup-
pressed Dvl-1-induced RhoA activation, while full-length
Daam1 had no apparent effect (Supplemental Figure S11),
which indicates that N-Daam1 functions as a dominant-
negative form of Daam1 for Dvl-induced RhoA activation in
N1E-115 cells, as reported previously in other cell types
(Habas et al., 2001).
DISCUSSION
RhoA activation is a key step in the Wnt-PCP signaling
pathway. Both genetic and biochemical studies in Drosophila
and mammalian cells demonstrated that Dvl mediates Wnt-
induced RhoA activation (Strutt et al., 1997; Winter et al.,
2001). However, the molecular mechanism of Dvl-mediated
RhoA activation is not well understood. In this study, we
identiﬁed Rho-GEFs that are responsible for Dvl-mediated
RhoA activation in the mammalian Wnt-PCP pathway by
analyzing the inhibitory effects of shRNA-assisted Rho-GEF
depletion on Dvl-induced neurite retraction in N1E-115
cells. Of 14 Rho-GEF shRNAs (including WGEF shRNA)
examined, only three shRNAs, targeting p114-RhoGEF, Lfc,
and LARG, suppressed Dvl-induced neurite retraction. They
also suppressed Wnt-3a–induced neurite retraction. Interest-
ingly, neither p114-RhoGEF nor Lfc shRNA had any signif-
icant effect on LPA-induced neurite retraction, but LARG
shRNA did suppress the neurite-retracting activity of LPA.
LARG was previously shown to be involved in LPA- and
semaphorin 4D-induced RhoA activation and neurite retrac-
tion (Fukuhara et al., 2000; Aurandt et al., 2002; Perrot et al.,
2002; Yamada et al., 2005). These results suggest that LARG is
involved in multiple signaling pathways that lead to RhoA
activation and neurite retraction, while p114-RhoGEF and Lfc
function preferentially in Wnt-3a–induced neurite retraction.
We also showed that p114-RhoGEF and Lfc shRNAs signif-
icantly suppressed Dvl- or Wnt-3a–induced RhoA activa-
tion, but LARG shRNA did not. Furthermore, p114-RhoGEF
and Lfc, but not LARG (at least in a full-length form), can
physically associate with Dvl and Daam1. Taken together,
these results suggest that p114-RhoGEF and Lfc are critically
involved in Wnt/Dvl-induced RhoA activation and neurite
retraction in N1E-115 cells by forming a complex with Dvl
and Daam1. In contrast, LARG is not directly involved in
Dvl-induced RhoA activation and probably has a more gen-
eral role in suppression of neurite outgrowth.
We showed that LARG shRNA suppressed Wnt/Dvl-
induced neurite retraction but had little effect on Dvl-in-
duced RhoA activation. This raises the question of how
LARG is involved in Wnt/Dvl-induced neurite retraction
Figure 7. Mapping of the binding regions of p114-RhoGEF and
Lfc. (A) Binding of p114-RhoGEF fragments to Dvl-1 and Daam1.
CFP-tagged p114-RhoGEF fragments were coexpressed with
Flag-Dvl-1-(165-367) or HA-N-Daam1 in HEK293 cells. Cell ly-
sates were immunoprecipitated with an anti-Flag or an anti-HA
antibody and analyzed by immunoblotting with an anti-GFP
antibody. (B) Binding of Lfc fragments to Dvl-1 and Daam1.
CFP-tagged Lfc fragments were coexpressed with Flag-Dvl-1-
(165-367) or HA-N-Daam1 in HEK293 cells. Cell lysates were
analyzed as in A. Schematic structures of p114-RhoGEF, Lfc, and
their fragments are shown.
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cell. One possible explanation is that LARG contributes to
the neurite retraction by activating any of the Rho family
GTPases other than RhoA (such as RhoB or RhoC) or other
cytoskeletal regulators that promote neurite retraction. In
this case, LARG knockdown would not affect RhoA activity
but could suppress Wnt/Dvl-induced neurite retraction by
lowering the activity of neurite-retracting factors. Another
possibility is that LARG is involved in RhoA activation only
in the limited region of the cell. In this case, LARG knock-
down would have little effect on the level of the total RhoA
activity. In this respect, a recent study demonstrated that
Dia1, one of the downstream effectors of RhoA, binds to and
activates LARG. It has been proposed that Dia1, LARG, and
RhoA constitute a positive feedback loop to potentiate the
RhoA signaling pathway (Kitzing et al., 2007). This suggests
the possibility that LARG contributes to neurite retraction
by locally activating RhoA through this positive feedback
mechanism. LARG may activate RhoA in the limited region
of the cell, such as the growing tip of the neurites. It is
possible that LARG shRNA suppresses Wnt/Dvl-induced
neurite retraction by decreasing the local level of RhoA
activity at the neurite tip via disconnecting the Dia1-LARG-
RhoA feedback loop.
WGEF was shown to be involved in Rho activation in the
Wnt-PCP pathway and to regulate convergent extension cell
movements in Xenopus gastrulation (Tanegashima et al.,
2008). Consistent with this report, we observed the binding
of WGEF to Dvl and Daam1 by coprecipitation experiments.
However, unlike p114-Rho-GEF or Lfc shRNA, WGEF
shRNA had no apparent effect on Wnt/Dvl-induced neurite
retraction in N1E-115 cells. Thus, WGEF is involved in Wnt/
Dvl-induced RhoA activation in Xenopus embryos, but not in
N1E-115 cells. Accordingly, Wnt/Dvl-induced RhoA activa-
tion appears to be mediated by distinct Rho-GEFs in a cell
type–dependent manner. The ineffectiveness of WGEF
shRNA in N1E-115 cells may be due to the low level of
expression of WGEF protein in the cells, compared with
those of p114-RhoGEF and Lfc proteins. Alternatively,
WGEF may require additional factors (that exist in Xenopus
embryo cells, but not in N1E-115 cells) to function. Further
studies are required to understand the mechanisms govern-
ing the cell type-speciﬁc functions of Rho-GEFs in the Wnt-
PCP pathway.
Lfc is a microtubule-associated Rho-GEF, which is
thought to mediate the cross-talk between microtubules and
the actin cytoskeleton (Ren et al., 1998; Krendel et al., 2002;
Birkenfeld et al., 2007). Lfc is highly expressed in the brain
and regulates dendritic spine morphology (Ryan et al., 2005).
p114-RhoGEF was shown to be activated by association with
the G subunits of heterotrimeric G proteins (Blomquist et
al., 2000; Niu et al., 2003). However, the roles of Lfc and
p114-RhoGEF in the regulation of neurite outgrowth were
still to be elucidated. Our study demonstrated that Lfc and
p114-RhoGEF are involved in Wnt/Dvl-induced neurite re-
traction in N1E-115 cells. p114-RhoGEF and Lfc have a sim-
ilar domain structure, composed of the closely related
DH-PH domains and the C-terminal coiled-coil domain,
although Lfc contains the extra C1 domain in the N-terminal
region (Rossman et al., 2005). Coprecipitation assays re-
vealed that both p114-RhoGEF and Lfc bind to N-Daam1
through the DH-PH-containing region. Additionally, we ob-
Figure 8. The Dvl-binding fragment of p114-RhoGEF or Lfc suppresses Dvl-induced neurite retraction. (A) Effects of expression of
p114-RhoGEF or Lfc fragments on Dvl-induced neurite retraction. N1E-115 cells were cotransfected with Flag-Dvl-1 and CFP or CFP-tagged
p114-RhoGEF or Lfc fragments, cultured for 24 h, and serum-starved for 24 h. Cells were then ﬁxed and immunostained with an anti-Flag
antibody. Merged images of phase-contrast, anti-Flag immunostaining (red), and CFP ﬂuorescence (cyan) are shown in the right. Scale bar,
50 m. (B) Quantitative analysis of the percentage of neurite-bearing cells. Data represent means  SD of three independent experiments (at
least 50 cells in each experiment). *p  0.01.
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weakly bound to Daam1, which indicates that the DH/PH
domains of these Rho-GEFs commonly have the potential to
bind to Daam1 and the conformational change to relieve the
DH/PH domain may be required for LARG to bind to
Daam1. Interestingly, p114-RhoGEF binds to the PDZ-con-
taining central region of Dvl through the C-terminal (568-
1016) region, but Lfc binds to Dvl through the N-terminal
(1-155) region. Overexpression of the Dvl-binding fragment
of p114-RhoGEF or Lfc suppressed Dvl-induced neurite re-
traction, indicating the important role of the interactions
between Dvl and these Rho-GEFs in Dvl-induced neurite
retraction. These fragments probably function as the domi-
nant-negative forms of Rho-GEFs by inhibiting Dvl binding
to endogenous p114-RhoGEF and Lfc.
Based on the results in this study and those previously
reported (Habas et al., 2001; Liu et al., 2008), we propose a
model for the signaling of Wnt-3a–induced RhoA activation
and the interactions of Dvl-1, Daam1, and p114-RhoGEF or
Lfc in the ternary complex (Figure 9). In nonstimulated cells,
Daam1 exists in an autoinhibited state by the intramolecular
interaction between its N-terminal GBD and C-terminal
DAD domains (Liu et al., 2008). Similarly, p114-RhoGEF and
Lfc presumably exist in the autoinhibited states before cell
stimulation (Schmidt and Hall, 2002; Meiri et al., 2009). Once
cells are stimulated by Wnt-3a treatment or Dvl overex-
pression, both Daam1 and Rho-GEFs are activated by
binding of Dvl, which relieves their autoinhibitory in-
tramolecular interactions. Additionally, the N-terminal
region of Daam1 interacts with the DH/PH domain of
Rho-GEFs, which probably facilitates the GDP-GTP ex-
change activity of Rho-GEFs, by tethering RhoA near the
DH/PH domain of Rho-GEFs and/or by stabilizing the
active conformation of Rho-GEFs. As previously reported
(Habas et al., 2001), overexpression of N-Daam1 suppressed
Dvl-induced RhoA activation. This may be caused by the
binding of N-Daam1 to the DAD domain of endogenous
Daam1, which leads to the inhibition of the interaction be-
tween Daam1 and Dvl, or by the sequestering of endoge-
nous RhoA by N-Daam1. More detailed biochemical and
structural analyses are required to understand the molecular
mechanisms of how the Dvl/Daam1/Rho-GEF ternary com-
plex is regulated and stimulates RhoA activity in response to
the Wnt signal.
Numerous studies have elucidated the speciﬁc roles of
individual Rho-GEFs in various signaling pathways. How-
ever, considering the existence of a large number of Rho-
GEF genes in mammalian genomes and the expression of
many distinct Rho-GEF proteins in the same cell, more com-
prehensive studies are required. In particular, research is
required to better understand the mechanisms whereby Rho
activity is differentially regulated. In this study, we per-
formed a search for Rho-GEFs involved in the Wnt-PCP
pathway. The 14 Rho-GEFs that are expressed in N1E-115
cells were knocked down, and three Rho-GEF shRNAs were
found to suppress Dvl-induced neurite retraction. This
study constitutes the ﬁrst step toward a genome-wide ap-
proach to knockdown Rho-GEF, using shRNAs targeting all
known Rho-GEF candidate genes (including 69 Dbl-like
genes, 11 Dock1-related genes and two SWAP70-like genes)
(Rossman et al., 2005). We anticipate that this approach will
lead to a more comprehensive understanding of the func-
tional roles of Rho-GEFs in the regulation of Rho family
GTPases in various aspects of cell activity, such as cytoskel-
etal reorganization, polarity formation, gene transcription,
cell growth, migration, neurite outgrowth, and tumor inva-
sion. In this study, we used a high-throughput screening
method to obtain shRNA constructs with effective gene-
silencing activity. This method can be applied to any gene,
even when the expression of the gene cannot be monitored
directly, due to either a lack of speciﬁc antibodies or very
low gene expression levels. Therefore, our approach will
contribute toward efforts to knock down large numbers of
genes simultaneously and can be applied to genome-wide
knockdown experiments.
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